NCT06936605View on ClinicalTrials.gov

RGD With Minimally Invasive Non-Surgical Technique in Treatment of Periodontal Intrabony Defect

NANot yet recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

September 20, 2025

Study Completion Date

October 20, 2025

Conditions
Intrabony DefectPeriodontal DiseasesAlveolar Bone Loss
Interventions
DRUG

RGD Peptide

RGD peptide is an integrin binding site

All Listed Sponsors
lead

Minia University

OTHER

NCT06936605 - RGD With Minimally Invasive Non-Surgical Technique in Treatment of Periodontal Intrabony Defect | Biotech Hunter | Biotech Hunter